Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-20
DOI
10.1038/s41388-021-01685-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Avapritinib: First Approval
- (2020) Sohita Dhillon DRUGS
- Ripretinib: First Approval
- (2020) Sohita Dhillon DRUGS
- Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial
- (2020) Michael C Heinrich et al. LANCET ONCOLOGY
- Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib
- (2020) Filip Janku et al. JOURNAL OF CLINICAL ONCOLOGY
- Resistance to avapritinib in PDGFRA-driven GIST is caused by secondary mutations in the PDGFRA kinase domain
- (2020) Susanne Grunewald et al. Cancer Discovery
- Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor
- (2019) Gerardo A. Vitiello et al. JOURNAL OF CLINICAL INVESTIGATION
- GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells
- (2018) Shu Z. Wiley et al. FASEB JOURNAL
- Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer
- (2018) Delphine Goehrig et al. GUT
- Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
- (2017) E Hessmann et al. GUT
- Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1
- (2017) Federica Ruffini et al. Oncotarget
- Platelet Derived Growth Factor Alpha (PDGFRα) Induces the Activation of Cardiac Fibroblasts by Activating c-Kit
- (2017) Lexun Wang et al. MEDICAL SCIENCE MONITOR
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor
- (2016) Phillip Zook et al. CLINICAL CANCER RESEARCH
- FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors
- (2016) Eileen Shi et al. Journal of Translational Medicine
- Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition
- (2016) Esther Ekpe-Adewuyi et al. Oncotarget
- Molecular Subtypes ofKIT/PDGFRAWild-Type Gastrointestinal Stromal Tumors
- (2016) Sosipatros A. Boikos et al. JAMA Oncology
- Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1
- (2015) Yujiro Hayashi et al. GASTROENTEROLOGY
- KITandPDGFRAMutations and the Risk of GI Stromal Tumor Recurrence
- (2015) Heikki Joensuu et al. JOURNAL OF CLINICAL ONCOLOGY
- Phosphoinositide 3-Kinase Inhibitors Combined with Imatinib in Patient-Derived Xenograft Models of Gastrointestinal Stromal Tumors: Rationale and Efficacy
- (2014) T. Van Looy et al. CLINICAL CANCER RESEARCH
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors
- (2013) Jason K. Sicklick et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth
- (2013) Badreddin Edris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment Withdrawal
- (2012) G. Floris et al. CLINICAL CANCER RESEARCH
- Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) George D Demetri et al. LANCET
- Twist1-Induced Invadopodia Formation Promotes Tumor Metastasis
- (2011) Mark A. Eckert et al. CANCER CELL
- A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors
- (2010) P. Schoffski et al. ANNALS OF ONCOLOGY
- Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)- Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors
- (2009) U. McDermott et al. CANCER RESEARCH
- Molecular Pathobiology of Gastrointestinal Stromal Sarcomas
- (2008) Christopher L. Corless et al. Annual Review of Pathology-Mechanisms of Disease
- Carcinoma-Associated Fibroblast-Like Differentiation of Human Mesenchymal Stem Cells
- (2008) P. J. Mishra et al. CANCER RESEARCH
- Paracrine Signaling by Platelet-Derived Growth Factor-CC Promotes Tumor Growth by Recruitment of Cancer-Associated Fibroblasts
- (2008) C. Anderberg et al. CANCER RESEARCH
- Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started